🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AmCad BioMed Corporation (TPEX:4188)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.05
-1.10 (-9.05%)
Nov 20, 2026, 1:30 PM CST

AmCad BioMed Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-55.64-55.72-50.58-45.31-53.49-25.54
Depreciation & Amortization
15.6715.471817.1617.2717.9
Other Amortization
0.330.330.280.30.350.38
Loss (Gain) From Sale of Assets
0.120.220.190.170.010.08
Loss (Gain) From Sale of Investments
-0.84-0.46-0.03-0-0.02-0
Stock-Based Compensation
0.550.642.90.680.820.54
Provision & Write-off of Bad Debts
-----0.05-0.1
Other Operating Activities
-16.37-15.71-2.312.16-0.86-1.35
Change in Accounts Receivable
7.3511.31-9.31-6.841.33-2.93
Change in Inventory
2.20.48-11.61-5.41-2.60.02
Change in Accounts Payable
-0.4-1.420.90.96-0.21-0.04
Change in Unearned Revenue
0.47-0.06-1.54-0.61-2.78-31.61
Change in Other Net Operating Assets
-5.43-2.151.25-4.866.033.68
Operating Cash Flow
-51.98-47.06-51.85-41.6-34.19-38.97
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.37-2.72-0.29-0.61-2.34
Sale (Purchase) of Intangibles
-0.33-0.33-0.33---
Investment in Securities
87.4659.51-182.8126.1928.7651.18
Other Investing Activities
-0.080.120.431.42-1.010.33
Investing Cash Flow
87.0658.93-185.4327.3127.1449.18

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--5.05-5.25-4.42-4.42-4.54
Lease Payments
-4.69-5.05-5.25-4.42-4.42-4.54
Net Debt Issued (Repaid)
-4.69-5.05-5.25-4.42-4.42-4.54
Issuance of Common Stock
--230.631.32--
Other Financing Activities
-0.03--0.01-6.8
Financing Cash Flow
-4.69-5.02225.38-3.1-4.42-11.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
30.396.85-11.9-17.39-11.47-1.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-51.98-47.44-54.57-41.89-34.81-41.3
Free Cash Flow Growth
------
Free Cash Flow Margin
-198.67%-155.85%-102.76%-64.20%-56.48%-48.14%
Free Cash Flow Per Share
-0.82-0.75-0.95-0.79-0.65-0.78
Levered Free Cash Flow
-27.47-30.86-40.17-29.01-20.2-33.04
Unlevered Free Cash Flow
-27.31-30.81-40.06-28.94-20.13-32.95
Free Cash Flow After Leases
-56.67-52.49-59.82-46.31-39.23-45.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.090.090.180.120.120.14
Cash Income Tax Paid
--0.01---
Change in Working Capital
4.28.17-20.31-16.761.76-30.88